TG Therapeutics CEO Michael Weiss' 2021 pay jumps 31% to $43M
TG Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 29, 2022
TG Therapeutics reported fiscal year 2021 executive compensation information on April 29, 2022.
In 2021, two executives at TG Therapeutics received on average a compensation package of $22M, a 12% increase compared to previous year.
Average pay of disclosed executives at TG Therapeutics
Michael S. Weiss, Chief Executive Officer, received $43M in total, which increased by 31% compared to 2020. 95% of Weiss' compensation, or $41M, was in stock awards. Weiss also received $783K in non-equity incentive plan and $1.3M in salary.
For fiscal year 2021, the median employee pay was $184,242 at TG Therapeutics. Therefore, the ratio of Michael S. Weiss' pay to the median employee pay was 232 to one.
Sean A. Power, Chief Financial Officer, received a compensation package of $1.5M, which decreased by 79% compared to previous year. 62% of the compensation package, or $939K, was in stock awards.
Related executives
You may also like
Source: SEC filing on April 29, 2022.